The Women’s Tennis Association (WTA) has implemented a new policy requiring players to undergo genetic testing to verify eligibility for the women’s category. The updated rule mandates screening for the SRY gene, found on the male Y chromosome, to determine eligibility. Players testing negative for the SRY gene are immediately qualified, while a positive result triggers further medical assessment. Refusal to undergo testing may result in disciplinary action.
The WTA states the policy aims to promote equal athletic opportunities and fair competition. The change follows discussions with members and reviews of international women’s sports organizations. Previously, the WTA allowed transgender athletes to compete if their testosterone levels remained below 2.5 nmol/L for at least two years. Tennis legend Martina Navratilova praised the move, calling it a 'step in the right direction.'
The policy aligns with recent actions by other sports governing bodies, including the International Olympic Committee and World Athletics, which have also adopted similar eligibility criteria.